Persistence of Severe Acute Respiratory Syndrome Coronavirus 2 in Aerosol Suspensions

We aerosolized severe acute respiratory syndrome coronavirus 2 and determined that its dynamic aerosol efficiency surpassed those of severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome. Although we performed experiment only once across several laboratories, our finding...

Descripción completa

Detalles Bibliográficos
Autores principales: Fears, Alyssa C., Klimstra, William B., Duprex, Paul, Hartman, Amy, Weaver, Scott C., Plante, Kenneth S., Mirchandani, Divya, Plante, Jessica Ann, Aguilar, Patricia V., Fernández, Diana, Nalca, Aysegul, Totura, Aysegul, Dyer, David, Kearney, Brian, Lackemeyer, Matthew, Bohannon, J. Kyle, Johnson, Reed, Garry, Robert F., Reed, Doug S., Roy, Chad J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2020
Materias:
Dispatch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7454081/
https://www.ncbi.nlm.nih.gov/pubmed/32568661
http://dx.doi.org/10.3201/eid2609.201806
Descripción
Sumario:We aerosolized severe acute respiratory syndrome coronavirus 2 and determined that its dynamic aerosol efficiency surpassed those of severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome. Although we performed experiment only once across several laboratories, our findings suggest retained infectivity and virion integrity for up to 16 hours in respirable-sized aerosols.

Ejemplares similares